Ology Bioservices   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Alachua FL United States (2000)
Status: Acquired by Reslience (2021)

Organization Overview

First Clinical Trial
2003
NCT00161837
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Ology Bioservices